Literature DB >> 17537080

Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine.

Sandra V Giannelli1, Kushang V Patel, B Gwen Windham, Francesco Pizzarelli, Luigi Ferrucci, Jack M Guralnik.   

Abstract

OBJECTIVES: To estimate in a community-dwelling elderly population the magnitude of renal function misclassification, occurring when persons with normal serum creatinine have reduced glomerular filtration rate (GFR), and to describe the participant characteristics related to misclassification.
DESIGN: Cross-sectional.
SETTING: Population-based study of older Italian people. PARTICIPANTS: Six hundred sixty participants aged 65 to 92 with normal serum creatinine. MEASUREMENTS: GFR was estimated using the Cockcroft-Gault equation and creatinine clearance (CrCl) calculated from 24-hour urine collection.
RESULTS: In participants with normal serum creatinine, 39% and 25% had moderate renal function impairment (GFR<60 mL/min) according to the Cockcroft-Gault equation and CrCl calculation, respectively. Prevalence of moderate renal impairment in those aged 65 to 74, 75 to 84, and 85 and older was 18.6%, 58.3%, and 96.8%, respectively (P for trend <.001) according to the Cockcroft-Gault equation, and 15%, 35.7%, and 58.7%, respectively (P for trend <.001) based on the CrCl calculation. In addition, female sex (P<.001) and normal or underweight (P<.05) were factors associated with high risk of misclassification.
CONCLUSION: Serum creatinine alone is one of the most widely used methods of assessing renal function in clinical practice despite its well-known poor correlation with GFR. A large proportion of older persons with impaired renal function are not diagnosed if clinicians rely solely on normal serum creatinine as evidence of normal renal function. Opportunities may be missed for slowing progression of kidney disease, managing comorbidities and complications related to renal impairment, and adjusting drug dosage for renal function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537080      PMCID: PMC2645624          DOI: 10.1111/j.1532-5415.2007.01196.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  37 in total

1.  Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.

Authors:  I Giatras; J Lau; A S Levey
Journal:  Ann Intern Med       Date:  1997-09-01       Impact factor: 25.391

2.  Screening for renal disease using serum creatinine: who are we missing?

Authors:  L Duncan; J Heathcote; O Djurdjev; A Levin
Journal:  Nephrol Dial Transplant       Date:  2001-05       Impact factor: 5.992

3.  Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines.

Authors:  W M McClellan; D F Knight; H Karp; W W Brown
Journal:  Am J Kidney Dis       Date:  1997-03       Impact factor: 8.860

Review 4.  Pathophysiology of progressive nephropathies.

Authors:  G Remuzzi; T Bertani
Journal:  N Engl J Med       Date:  1998-11-12       Impact factor: 91.245

5.  Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data.

Authors: 
Journal:  Ann Intern Med       Date:  2001-03-06       Impact factor: 25.391

6.  Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Authors:  T H Jafar; C H Schmid; M Landa; I Giatras; R Toto; G Remuzzi; G Maschio; B M Brenner; A Kamper; P Zucchelli; G Becker; A Himmelmann; K Bannister; P Landais; S Shahinfar; P E de Jong; D de Zeeuw; J Lau; A S Levey
Journal:  Ann Intern Med       Date:  2001-07-17       Impact factor: 25.391

7.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

8.  Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study.

Authors:  L Ferrucci; S Bandinelli; E Benvenuti; A Di Iorio; C Macchi; T B Harris; J M Guralnik
Journal:  J Am Geriatr Soc       Date:  2000-12       Impact factor: 5.562

9.  Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995

10.  The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

Authors:  L M Laffel; J B McGill; D J Gans
Journal:  Am J Med       Date:  1995-11       Impact factor: 4.965

View more
  18 in total

1.  Cystatin C and cognitive impairment 10 years later in older women.

Authors:  Yelena Slinin; Katherine W Peters; Areef Ishani; Kristine Yaffe; Howard A Fink; Katie L Stone; Michael Steffes; Kristine E Ensrud
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-11-01       Impact factor: 6.053

2.  Natural history of older adults with impaired kidney function: the InCHIANTI study.

Authors:  Sandra V Giannelli; Christophe E Graf; François R Herrmann; Jean-Pierre Michel; Kushang V Patel; Francesco Pizzarelli; Luigi Ferrucci; Jack Guralnik
Journal:  Rejuvenation Res       Date:  2011-09-28       Impact factor: 4.663

Review 3.  Treatment approaches to small renal masses in patients of advanced age (≥75 years).

Authors:  Muhammet Fuat Özcan; Serkan Altınova; Ali Atan
Journal:  Turk J Urol       Date:  2018-07

4.  Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology.

Authors:  Adriana Albini; Francesco Donatelli; Chiara Focaccetti; Mario Milco D'Elios; Douglas M Noonan
Journal:  Intern Emerg Med       Date:  2012-09-02       Impact factor: 3.397

5.  C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease.

Authors:  Diana Jalal; Michel Chonchol; Thorleif Etgen; Dirk Sander
Journal:  J Nephrol       Date:  2012 Sep-Oct       Impact factor: 3.902

6.  Basic assessment of the older cancer patient.

Authors:  Martine Extermann
Journal:  Curr Treat Options Oncol       Date:  2011-09

7.  Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging.

Authors:  Carmen A Peralta; Anne Lee; Michelle C Odden; Lenny Lopez; Adina Zeki Al Hazzouri; John Neuhaus; Mary N Haan
Journal:  J Am Geriatr Soc       Date:  2012-12-18       Impact factor: 5.562

8.  Plasma polyunsaturated fatty acids and the decline of renal function.

Authors:  Fulvio Lauretani; Richard D Semba; Stefania Bandinelli; Edgar R Miller; Carmelinda Ruggiero; Antonio Cherubini; Jack M Guralnik; Luigi Ferrucci
Journal:  Clin Chem       Date:  2008-01-17       Impact factor: 8.327

9.  High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine.

Authors:  O Kenrik Duru; Roberto B Vargas; Dulcie Kermah; Allen R Nissenson; Keith C Norris
Journal:  J Gen Intern Med       Date:  2008-11-06       Impact factor: 5.128

10.  A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy.

Authors:  Suwen Qi; Xin Ouyang; Linqian Wang; Wujian Peng; Jinli Wen; Yong Dai
Journal:  Clin Transl Sci       Date:  2012-08-07       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.